 |
Psychiatry Archives 1. Blouin AM, Fried I, Wilson CL, Staba RJ, Behnke
EJ, Lam HA, Maidment NT,Karlsson KÆ, Lapierre JL, Siegel JM. Human
hypocretin and melanin-concentrating hormone levels are linked to emotion
and social interaction. Nat Commun. 2013 Mar 5;4:1547. 2. Brandt J, Sullivan C, Burrell LE 2nd, Rogerson
M, Anderson A. Internet-based screening for dementia risk. PLoS One.
2013;8(2):e57476. 3. Chen H, Wang N, Zhao X, Ross CA, O'Shea KS,
McInnis MG. Gene expression alterations in bipolar disorder postmortem
brains. Bipolar Disord. 2013 Mar;15(2):177-87. 4. Findling RL, Correll CU, Nyilas M, Forbes RA,
McQuade RD, Jin N, Ivanova S, Mankoski R, Carson WH, Carlson GA. Aripiprazole
for the treatment of pediatric bipolar I disorder: a 30-week, randomized,
placebo-controlled study. Bipolar Disord. 2013 Mar;15(2):138-149. 5. Kamdar BB, King LM, Collop NA, Sakamuri S,
Colantuoni E, Neufeld KJ, Bienvenu OJ, Rowden AM, Touradji P, Brower
RG, Needham DM. The Effect of a Quality Improvement Intervention on
Perceived Sleep Quality and Cognition in a Medical ICU*. Crit Care Med.
2013 Mar;41(3):800-809. 6. Liang NC, Smith ME, Moran TH. Palatable food
avoidance and acceptance learning with different stressors in female
rats. Neuroscience. 2013 Apr 3;235:149-58. 7. Maclean KA, Johnson MW, Reissig CJ, Prisinzano
TE, Griffiths RR. Dose-related effects of salvinorin A in humans: dissociative,
hallucinogenic, and memory effects. Psychopharmacology (Berl). 2013
Mar;226(2):381-92. 8. Rosenberg PB, Wong DF, Edell SL, Ross JS, Joshi
AD, Braši? JR, Zhou Y, Raymont V, Kumar A, Ravert HT, Dannals RF,
Pontecorvo MJ, Skovronsky DM, Lyketsos CG. Cognition and Amyloid Load
in Alzheimer Disease Imaged With Florbetapir F 18(AV-45) Positron Emission
Tomography. Am J Geriatr Psychiatry. 2013 Mar;21(3):272-8. 9. Uhart M, Weerts EM, McCaul ME, Guo X, Yan X,
Kranzler HR, Li N, Wand GS. GABRA2 markers moderate the subjective effects
of alcohol. Addict Biol. 2013Mar;18(2):357-369. 1. Aretouli E, Tsilidis
KK, Brandt J. Four-year outcome of mild cognitive impairment: The contribution
of executive dysfunction. Neuropsychology. 2013 Jan;27(1):95-106. 2. Crum RM, La Flair L, Storr CL, Green KM, Stuart
EA, Alvanzo AA, Lazareck S, Bolton JM, Robinson J, Sareen J, Mojtabai
R. Reports of drinking to self-medicate anxiety symptoms: longitudinal
assessment for subgroups of individuals with alcohol dependence. Depress
Anxiety. 2013 Feb;30(2):174-83. 3. Dailey MJ, Moran TH. Glucagon-like peptide
1 and appetite. Trends Endocrinol Metab. 2013 Feb;24(2):85-91. 4. Dunn KE, Defulio A, Everly JJ, Donlin WD, Aklin
WM, Nuzzo PA, Leoutsakos JM, Umbricht A, Fingerhood M, Bigelow GE, Silverman
K. Employment-based reinforcement of adherence to oral naltrexone treatment
in unemployed injection drug users. Exp Clin Psychopharmacol. 2013 Feb;21(1):74-83.
doi: 10.1037/a0030743. 5. Goodwin AK, Kaminski BJ, Weerts EM. Self-administration
of gamma-hydroxybutyric acid (GHB) precursors gamma-butyrolactone (GBL)
and 1,4-butanediol (1,4-BD) in baboons. Psychopharmacology (Berl). 2013
Feb;225(3):637-46. 6. Jones HE, Chisolm MS, Jansson LM, Terplan M.
Naltrexone in the treatment of opioid-dependent pregnant women: the
case for a considered and measured approach to research. Addiction.
2013 Feb;108(2):233-47. 7. Liang NC, Bello NT, Moran TH. Additive feeding
inhibitory and aversive effects of naltrexone and exendin-4 combinations.
Int J Obes (Lond). 2013 Feb;37(2):272-8. 8. Miller L, Riddle MA, Pruitt D, Zachik A, Dosreis
S. Antipsychotic treatment patterns and aggressive behavior among adolescents
in residential facilities. J Behav Health Serv Res. 2013 Jan;40(1):97-110.
9. Papazoglou A, Jacobson LA, Zabel TA. More than
intelligence: distinct cognitive/behavioral clusters linked to adaptive
dysfunction in children. J Int Neuropsychol Soc. 2013 Feb;19(2):189-97.
10. Weerts EM, McCaul ME, Kuwabara H, Yang X,
Xu X, Dannals RF, Frost JJ, Wong DF, Wand GS. Influence of OPRM1 Asn40Asp
variant (A118G) on [11C]carfentanil binding potential: preliminary findings
in human subjects. Int J Neuropsychopharmacol. 2013 Feb;16(1):47-53.
1. Barber AD, Caffo BS, Pekar JJ, Mostofsky SH.
Developmental changes in within- and between-network connectivity between
late childhood and adulthood. Neuropsychologia. 2013 Jan;51(1):156-67.
2. Blouin AM, Han S, Pearce AM, Cheng K, Lee JJ,
Johnson AW, Wang C, During MJ, Holland PC, Shaham Y, Baraban JM, Reti
IM. Role of medial prefrontal cortex Narp in the extinction of morphine
conditioned place preference. Learn Mem. 2013 Jan 15;20(2):75-9. 3. Campbell CM, Jamison RN, Edwards RR. Psychological
screening/phenotyping as predictors for spinal cord stimulation. Curr
Pain Headache Rep. 2013 Jan;17(1):307. 4. Liu J, Li T, Yang D, Ma R, Moran TH, Smith
WW. Synphilin-1 alters metabolic homeostasis in a novel Drosophila obesity
model. Int J Obes (Lond). 2012 Dec;36(12):1529-36. 5. McClure EA, Vandrey RG, Johnson MW, Stitzer
ML. Effects of varenicline on abstinence and smoking reward following
a programmed lapse. Nicotine Tob Res. 2013 Jan;15(1):139-48. 6. Mojtabai R, Crum RM. Perceived unmet need for
alcohol and drug use treatments and future use of services: Results
from a longitudinal study. Drug Alcohol Depend. 2013 Jan 1;127(1-3):59-64.
7. Price GR, Mazzocco MM, Ansari D. Why Mental
Arithmetic Counts: Brain Activation during Single Digit Arithmetic Predicts
High School Math Scores. J Neurosci. 2013 Jan 2;33(1):156-63. 8. Specht MW, Woods DW, Nicotra CM, Kelly LM,
Ricketts EJ, Conelea CA, Grados MA, Ostrander RS, Walkup JT. Effects
of tic suppression: Ability to suppress, rebound, negative reinforcement,
and habituation to the premonitory urge. Behav Res Ther. 2013 Jan;51(1):24-30.
9. Wand GS, Weerts EM, Kuwabara H, Wong DF, Xu
X, McCaul ME. The relationship between naloxone-induced cortisol and
delta opioid receptor availability in mesolimbic structures is disrupted
in alcohol-dependent subjects. Addict Biol. 2013 Jan;18(1):181-92. 1. Angelino AF, Bone
A, Kuehl AK. A neuropsychiatric perspective of phenylketonuria ii: needs
assessment for a psychiatric presence. Psychosomatics. 2012 Nov;53(6):541-9.
2. Bi S, Kim YJ, Zheng F. Dorsomedial hypothalamic
NPY and energy balance control. Neuropeptides. 2012 Dec;46(6):309-14 3. Bone A, Kuehl AK, Angelino AF. A neuropsychiatric
perspective of phenylketonuria I: overview of phenylketonuria and its
neuropsychiatric sequelae. Psychosomatics. 2012 Nov;53(6):517-23. 4. DeFulio A, Silverman K. The use of incentives
to reinforce medication adherence. Prev Med. 2012 Nov;55 Suppl:S86-94.
5. Gitlin LN, Kales HC, Lyketsos CG. Nonpharmacologic
management of behavioral symptoms in dementia. JAMA. 2012 Nov 21;308(19):2020-9. 6. Kalb LG, Stuart EA, Freedman B, Zablotsky B,
Vasa R. Psychiatric-related emergency department visits among children
with an autism spectrum disorder. Pediatr Emerg Care. 2012 Dec;28(12):1269-76.
7. Kowalski S, Colantuoni E, Lau B, Keruly J,
McCaul ME, Hutton HE, Moore RD, Chander G. Alcohol consumption and CD4
T-cell count response among persons initiating antiretroviral therapy.
J Acquir Immune Defic Syndr. 2012 Dec 1;61(4):455-61. 8. Rahn KA, Watkins CC, Alt J, Rais R, Stathis
M, Grishkan I, Crainiceau CM, Pomper MG, Rojas C, Pletnikov MV, Calabresi
PA, Brandt J, Barker PB, Slusher BS, Kaplin AI. Inhibition of Glutamate
Carboxypeptidase II (GCPII) activity as a treatment for cognitive impairment
in multiple sclerosis. Proc Natl Acad Sci U S A. 2012 Dec 4;109(49):20101-6.
9. Rosenberg PB, Mielke MM, Han D, Leoutsakos
JS, Lyketsos CG, Rabins PV, Zandi PP, Breitner JC, Norton MC, Welsh-Bohmer
KA, Zuckerman IH, Rattinger GB, GreenRC, Corcoran C, Tschanz JT. The
association of psychotropic medication use with the cognitive, functional,
and neuropsychiatric trajectory of Alzheimer's disease. Int J Geriatr
Psychiatry. 2012 Dec;27(12):1248-57 10. Stephens MA, McCaul ME, Weerts EM, Wand G.
Serotonin transporter-linked polymorphic region (5-HTTLPR) genotype
is associated with cortisol responsivity to naloxone challenge. Psychopharmacology
(Berl). 2012 Nov;224(2):223-30. 11. Tighe SK, Reading SA, Rivkin P, Caffo B, Schweizer
B, Pearlson G, Potash JB, Depaulo JR, Bassett SS. Total white matter
hyperintensity volume in bipolar disorder patients and their healthy
relatives. Bipolar Disord. 2012 Dec;14(8):888-893. 1. Goes FS, Hamshere
ML, Seifuddin F, Pirooznia M, Belmonte-Mahon P, Breuer R, Schulze T,
Nöthen M, Cichon S, Rietschel M, Holmans P, Zandi PP; Bipolar Genome
Study (BiGS), Craddock N, Potash JB. Genome-wide association of mood-incongruent
psychotic bipolar disorder. Transl Psychiatry. 2012 Oct 23;2:e180. 2. Jin J, Cheng Y, Zhang Y, Wood W, Peng Q, Hutchison
E, Mattson MP, Becker KG, Duan W. Interrogation of brain miRNA and mRNA
expression profiles reveals a molecular regulatory network that is perturbed
by mutant huntingtin. J Neurochem. 2012 Nov;123(4):477-90. 3. Kalb LG, Freedman B, Foster C, Menon D, Landa
R, Kishfy L, Law P. Determinants of appointment absenteeism at an outpatient
pediatric autism clinic. J Dev Behav Pediatr. 2012 Nov;33(9):685-97.
4. Munro CA, Workman CI, Kramer E, Hermann C,
Ma Y, Dhawan V, Chaly T, Eidelberg D, Smith GS. Serotonin modulation
of cerebral glucose metabolism: sex and age effects. Synapse. 2012 Nov;66(11):955-64.
5. Munro CA, Winicki JM, Schretlen DJ, Gower EW,
Turano KA, Muñoz B, Keay L, Bandeen-Roche K, West SK. Sex differences
in cognition in healthy elderly individuals. Neuropsychol Dev Cogn B
Aging Neuropsychol Cogn. 2012 Nov;19(6):759-68. 6. Shao H, Breitner JC, Whitmer RA, Wang J, Hayden
K, Wengreen H, Corcoran C, Tschanz J, Norton M, Munger R, Welsh-Bohmer
K, Zandi PP; For the Cache County Investigators. Hormone therapy and
Alzheimer disease dementia: New findings from the Cache County Study.
Neurology. 2012 Oct 30;79(18):1846-1852. 7. Silverman K, Defulio A, Sigurdsson SO. Maintenance
of reinforcement to address the chronic nature of drug addiction. Prev
Med. 2012 Nov;55 Suppl:S46-53. 8. Soto PL, Wilcox KM, Zhou Y, Ator NA, Riddle
MA, Wong DF, Weed MR. Long-term exposure to oral methylphenidate or
dl-amphetamine mixture in peri-adolescent rhesus monkeys: effects on
physiology, behavior, and dopamine system development. Neuropsychopharmacology.
2012 Nov;37(12):2566-79. 9. Sun B, Purcell RH, Terrillion CE, Yan J, Moran
TH, Tamashiro KL. Maternal high-fat diet during gestation or suckling
differentially affects offspring leptin sensitivity and obesity. Diabetes.
2012 Nov;61(11):2833-41. 10. Yang D, Li T, Liu Z, Arbez N, Yan J,
Moran TH, Ross CA, Smith WW. LRRK2 kinase activity mediates toxic interactions
between genetic mutation and oxidative stress in a Drosophila model:
suppression by curcumin. Neurobiol Dis. 2012 Sep;47(3):385-92. 1. Black BS, Johnston
D, Morrison A, Rabins PV, Lyketsos CG, Samus QM. Quality of life of
community-residing persons with dementia based on self-rated and caregiver-rated
measures. Qual Life Res. 2012 Oct;21(8):1379-89. 2. Guo Z, Rudow G, Pletnikova O, Codispoti KE,
Orr BA, Crain BJ, Duan W, Margolis RL, Rosenblatt A, Ross CA, Troncoso
JC. Striatal neuronal loss correlates with clinical motor impairment
in Huntington's disease. Mov Disord. 2012 Sep 15;27(11):1379-86. 3. Leoutsakos JM, Han D, Mielke MM, Forrester
SN, Tschanz JT, Corcoran CD, Green RC, Norton MC, Welsh-Bohmer KA, Lyketsos
CG. Effects of general medical health on Alzheimer's progression: the
Cache County Dementia Progression Study. Int Psychogeriatr. 2012 Oct;24(10):1561-70.
4. Tuten M, Fitzsimons H, Chisolm MS, Nuzzo PA,
Jones HE. Contingent incentives reduce cigarette smoking among pregnant,
methadone-maintained women: results of an initial feasibility and efficacy
randomized clinical trial. Addiction. 2012 Oct;107(10):1868-77. 5. Unschuld PG, Joel SE, Pekar JJ, Reading
SA, Oishi K, McEntee J, Shanahan M, Bakker A, Margolis RL, Bassett SS,
Rosenblatt A, Mori S, van Zijl PC, Ross CA, Redgrave GW. Depressive
symptoms in prodromal Huntington's Disease correlate with Stroop-interference
related functional connectivity in the ventromedial prefrontal cortex.
Psychiatry Res. 2012 Aug;203(2-3):166-74. 1. Kaminski BJ, Duke
AN, Weerts EM. Effects of naltrexone on alcohol drinking patterns and
extinction of alcohol seeking in baboons. Psychopharmacology (Berl).
2012 Sep;223(1):55-66. 2. Kelly P, Frosch E. Recognition of delirium
on pediatric hospital services. Psychosomatics. 2012 Sep;53(5):446-51.
3. Landa RJ, Gross AL, Stuart EA, Bauman M. Latent
class analysis of early developmental trajectory in baby siblings of
children with autism. J Child Psychol Psychiatry. 2012 Sep;53(9):986-96.
4. Munro CA, Workman CI, Kramer E, Hermann C,
Ma Y, Dhawan V, Chaly T, Eidelberg D, Smith GS. Serotonin modulation
of cerebral glucose metabolism: Sex and age effects. Synapse. 2012 Nov;66(11):955-64.
doi: 10.1002/syn.21590. 5. Reissig CJ, Carter LP, Johnson MW, Mintzer
MZ, Klinedinst MA, Griffiths RR. High doses of dextromethorphan, an
NMDA antagonist, produce effects similar to classic hallucinogens. Psychopharmacology
(Berl). 2012 Sep;223(1):1-15. 6. Sevransky JE, Bienvenu OJ, Neufeld KJ, Needham
DM. Treatment of four psychiatric emergencies in the intensive care
unit. Crit Care Med. 2012 Sep;40(9):2662-70. 7. Tek S, Landa RJ. Differences in autism symptoms
between minority and non-minority toddlers. J Autism Dev Disord. 2012
Sep;42(9):1967-73. 8. Vannorsdall TD, Schretlen DJ, Andrejczuk M,
Ledoux K, Bosley LV, Weaver JR, Skolasky RL, Gordon B. Altering automatic
verbal processes with transcranial direct current stimulation. Front
Psychiatry. 2012;3:73. 9. Vasa RA, Anderson C, Marvin AR, Rosenberg RE,
Law JK, Thorn J, Sarphare G, Law PA. Mood disorders in mothers of children
on the autism spectrum are associated with higher functioning autism.
Autism Res Treat. 2012 10. Wachtel LE, Dhossche DM, Reti IM, Hughes-Wheatland
R. Stability of intellectual functioning during maintenance electroconvulsive
therapy. Pediatr Neurol. 2012 Sep;47(3):219-21. 11. Wand GS, Weerts EM, Kuwabara H, Wong DF, Xu
X, McCaul ME. The relationship between naloxone-induced cortisol and
mu opioid receptor availability in mesolimbic structures is disrupted
in alcohol dependent subjects. Alcohol. 2012 Sep;46(6):511-7. 12. Yi J, Torres J, Azner Y, Vaidya P, Schiavi
A, Reti IM. Flumazenil Pretreatment in Benzodiazepine-Free Patients:
A Novel Method for Managing Declining ECT Seizure Quality. J ECT. 2012
Sep;28(3):185-9. 1. Boersma GJ, Salton
SR, Spritzer PM, Steele CT, Carbone DL. Models and Mechanisms of Metabolic
Regulation: Genes, Stress, and the HPA and HPG Axes. Horm Metab Res.
2012 Jul;44(8):598-606. 2. Goes FS, McCusker MG, Bienvenu OJ, Mackinnon
DF, Mondimore FM, Schweizer B; National Institute of Mental Health Genetics
Initiative Bipolar Disorder Consortium, Depaulo JR, Potash JB. Co-morbid
anxiety disorders in bipolar disorder and major depression: familial
aggregation and clinical characteristics of co-morbid panic disorder,
social phobia, specific phobia and obsessive-compulsive disorder. Psychol
Med. 2012 Jul;42(7):1449-59. 3. Hatzimanolis A, Smyrnis N, Avramopoulos D,
Stefanis CN, Evdokimidis I, Stefanis NC. Bipolar disorder ANK3 risk
variant effect on sustained attention is replicated in a large healthy
population. Psychiatr Genet. 2012 Aug;22(4):210-3. 4. Jones HE, Kaltenbach K, Heil SH, Stine SM,
Coyle MG, Arria AM, O'Grady KE, Selby P, Martin PR, Jansson L, Fischer
G. Intrauterine abstinence syndrome (IAS) during buprenorphine inductions
and methadone tapers: can we assure the safety of the fetus? J Matern
Fetal Neonatal Med. 2012 Jul;25(7):1197-201. 5. Kaminsky Z, Tochigi M, Jia P, Pal M, Mill J,
Kwan A, Ioshikhes I, Vincent JB, Kennedy JL, Strauss J, Pai S, Wang
SC, Petronis A. A multi-tissue analysis identifies HLA complex group
9 gene methylation differences in bipolar disorder. Mol Psychiatry.
2012 Jul;17(7):728-40. 6. Keeton CP, Crosby Budinger M. Social phobia
and selective mutism. Child Adolesc Psychiatr Clin N Am. 2012 Jul;21(3):621-41 7. Kidorf M, King VL, Gandotra N, Kolodner K,
Brooner RK. Improving treatment enrollment and re-enrollment rates of
syringe exchangers: 12-month outcomes. Drug Alcohol Depend. 2012 Jul
1;124(1-2):162-6. 8. Mahon PB, Eldridge H, Crocker B, Notes L, Gindes
H, Postell E, King S, Potash JB, Ratnanather JT, Barta PE. An MRI study
of amygdala in schizophrenia and psychotic bipolar disorder. Schizophr
Res. 2012 Jul;138(2-3):188-91. 9. Neufeld KJ, Alvanzo A, King VL, Feldman L,
Hsu JH, Rastegar DA, Colbert JM, Mackinnon DF. A collaborative approach
to teaching medical students how to screen, intervene, and treat substance
use disorders. Subst Abus. 2012 Jul;33(3):286-91. 10. Onigu-Otite EC, Belcher HM. Maternal drug
abuse history, maltreatment, and functioning in a clinical sample of
urban children. Child Abuse Negl. 2012 Jun;36(6):491-7. 11. Seifuddin F, Mahon PB, Judy J, Pirooznia M,
Jancic D, Taylor J, Goes FS, Potash JB, Zandi PP. Meta-analysis of genetic
association studies on bipolar disorder. Am J Med Genet B Neuropsychiatr
Genet. 2012 Jul;159B(5):508-18. 12. Wang L, Potter GG, Krishnan RK, Dolcos F,
Smith GS, Steffens DC. Neural correlates associated with cognitive decline
in late-life depression. Am J Geriatr Psychiatry. 2012 Aug;20(8):653-63.
13. Watkins CC, Treisman GJ. Neuropsychiatric
complications of aging with HIV. J Neurovirol. 2012 Aug;18(4):277-90.
1. Henry PK, Umbricht
A, Kleykamp BA, Vandrey R, Strain EC, Bigelow GE, Mintzer MZ. Comparison
of cognitive performance in methadone maintenance patients with and
without current cocaine dependence. Drug Alcohol Depend. 2012 Jul 1;124(1-2):167-71.
2. Himes SK, Goodwin RS, Rock CM, Jones HE, Johnson
RE, Wilkins DG, Huestis MA. Methadone and metabolites in hair of methadone-assisted
pregnant women and their infants. Ther Drug Monit. 2012 Jun;34(3):337-344.
3. Tuten M, Svikis DS, Keyser-Marcus L, O'Grady
KE, Jones HE. Lessons learned from a randomized trial of fixed and escalating
contingency management schedules in opioid-dependent pregnant women.
Am J Drug Alcohol Abuse. 2012 Jul;38(4):286-92. 4. Unschuld PG, Edden RA, Carass A, Liu X, Shanahan
M, Wang X, Oishi K, Brandt J, Bassett SS, Redgrave GW, Margolis RL,
van Zijl PC, Barker PB, Ross CA. Brain metabolite alterations and cognitive
dysfunction in early Huntington's disease. Mov Disord. 2012 Jun;27(7):895-902. 1. Bigelow GE, Preston
KL, Schmittner J, Dong Q, Gastfriend DR. Opioid challenge evaluation
of blockade by extended-release naltrexone in opioid-abusing adults:
Dose-effects and time-course. Drug Alcohol Depend. 2012 Jun 1;123(1-3):57-65. 2. Buenaver LF, Quartana PJ, Grace EG, Sarlani
E, Simango M, Edwards RR, Haythornthwaite JA, Smith MT. Evidence for
indirect effects of pain catastrophizing on clinical pain among myofascial
temporomandibular disorder participants: The mediating role of sleep
disturbance. Pain. 2012 Jun;153(6):1159-66. 3. Drake KL, Ginsburg GS. Family factors in the
development, treatment, and prevention of childhood anxiety disorders.
Clin Child Fam Psychol Rev. 2012 Jun;15(2):144-62. 4. Fields C, Drye L, Vaidya V, Lyketsos C; for
the ADAPT Research Group. Celecoxib or naproxen treatment does not benefit
depressive symptoms in persons age 70 and older: findings from a randomized
controlled trial. Am J Geriatr Psychiatry. 2012 Jun;20(6):505-513. 5. Gallegos J, Vaidya P, D'Agati D, Jayaram G,
Nguyen T, Tripathi A, Trivedi JK, Reti IM. Decreasing adverse outcomes
of unmodified electroconvulsive therapy: suggestions and possibilities.
J ECT. 2012 Jun;28(2):77-81. 6. Johnson MW, Andrew Sewell R, Griffiths RR.
Psilocybin dose-dependently causes delayed, transient headaches in healthy
volunteers. Drug Alcohol Depend. 2012 Jun1;123(1-3):132-40. 7. Johnson MW, Bruner NR. The Sexual Discounting
Task: HIV risk behavior and the discounting of delayed sexual rewards
in cocaine dependence. Drug Alcohol Depend. 2012 Jun 1;123(1-3):15-21.
8. Johnson MW. An efficient operant choice procedure
for assessing delay discounting in humans: Initial validation in cocaine-dependent
and control individuals. Exp Clin Psychopharmacol. 2012 Jun;20(3):191-204.
9. Landa RJ, Gross AL, Stuart EA, Bauman M. Latent
class analysis of early developmental trajectory in baby siblings of
children with autism. J Child Psychol Psychiatry. 2012 May 10. 10. Mahon PB, Eldridge H, Crocker B, Notes L,
Gindes H, Postell E, King S, Potash JB, Ratnanather JT, Barta PE. An
MRI study of amygdala in schizophrenia and psychotic bipolar disorder.
Schizophr Res. 2012 Jul;138(2-3):188-91. 11. McHugh PR, Slavney PR. Mental illness--comprehensive
evaluation or checklist? N Engl J Med. 2012 May 17;366(20):1853-5. 12. Ratovitski T, Chighladze E, Arbez N, Boronina
T, Herbrich S, Cole RN, Ross CA. Huntingtin protein interactions altered
by polyglutamine expansion as determined by quantitative proteomic analysis.
Cell Cycle. 2012 May 15;11(10):2006-21. 13. Seifuddin F, Mahon PB, Judy J, Pirooznia M,
Jancic D, Taylor J, Goes FS, Potash JB, Zandi PP. Meta-analysis of genetic
association studies on bipolar disorder. Am J Med Genet B Neuropsychiatr
Genet. 2012 Jul;159(5):508-18. 14. Shahani N, Sawa A. Protein S-nitrosylation:
Role for nitric oxide signaling in neuronal death. Biochim Biophys Acta.
2012 Jun;1820(6):736-42. 15. Weed M, Adams RJ, Hienz RD, Meulendyke KA,
Linde ME, Clements JE, Mankowski JL, Zink MC. SIV/macaque model of HIV
infection in cocaine users: minimal effects of cocaine on behavior,
virus replication, and CNS inflammation. J Neuroimmune Pharmacol. 2012
Jun;7(2):401-11. 1. Goodin BR, Quinn
NB, King CD, Page GG, Haythornthwaite JA, Edwards RR, Stapleton LM,
McGuire L. Enhanced cortisol increase upon awakening is associated with
greater pain ratings but not salivary cortisol or soluble tumor necrosis
factor-? Receptor II responses to acute pain. Clin J Pain. 2012 May;28(4):291-9.
2. Leoutsakos JM, Muthen BO, Breitner JC, Lyketsos
CG; ADAPT Research Team.Effects of non-steroidal anti-inflammatory drug
treatments on cognitive declinevary by phase of pre-clinical Alzheimer
disease: findings from the randomized controlled Alzheimer's Disease
Anti-inflammatory Prevention Trial. Int J Geriatr Psychiatry. 2012 Apr;27(4):364-74.
3. Mielke MM, Leoutsakos JM, Corcoran CD, Green
RC, Norton MC, Welsh-Bohmer KA, Tschanz JT, Lyketsos CG. Effects of
Food and Drug Administration-approved medications for Alzheimer's disease
on clinical progression. Alzheimers Dement. 2012 May;8(3):180-7. 4. Raches D, Mazzocco MM. Emergence and nature
of mathematical difficulties in young children with barth syndrome.
J Dev Behav Pediatr. 2012 May;33(4):328-35. 5. Sheffer C, Mackillop J, McGeary J, Landes R,
Carter L, Yi R, Jones B, Christensen D, Stitzer M, Jackson L, Bickel
W. Delay discounting, locus of control, and cognitive impulsiveness
independently predict tobacco dependence treatment outcomes in a highly
dependent, lower socioeconomic group of smokers. Am J Addict. 2012 May;21(3):221-232.
6. Tuten M, Defulio A, Jones HE, Stitzer M. Abstinence-contingent
recovery housing and reinforcement-based treatment following opioid
detoxification. Addiction. 2012 May;107(5):973-82. 7. Vannorsdall TD, Maroof DA, Gordon B,
Schretlen DJ. Ideational fluency as a domain of human cognition. Neuropsychology.
2012 May;26(3):400-5. 1. Bienvenu OJ, Colantuoni
E, Mendez-Tellez PA, Dinglas VD, Shanholtz C, Husain N, Dennison CR,
Herridge MS, Pronovost PJ, Needham DM. Depressive symptoms and impaired
physical function after acute lung injury: a 2-year longitudinal study.
Am J Respir Crit Care Med. 2012 Mar 1;185(5):517-24. 2. Harrison JN, Cluxton-Keller F, Gross D. Antipsychotic
medication prescribing trends in children and adolescents. J Pediatr
Health Care. 2012 Mar;26(2):139-45. 3. Kamiya A, Sedlak TW, Pletnikov MV. DISC1 Pathway
in Brain Development: Exploring Therapeutic Targets for Major Psychiatric
Disorders. Front Psychiatry. 2012;3:25. 4. Lee HB, Richardson AK, Black BS, Shore AD,
Kasper JD, Rabins PV. Race and cognitive decline among community-dwelling
elders with mild cognitive impairment: Findings from the Memory and
Medical Care Study. Aging Ment Health. 2012 Apr;16(3):372-7. 5. Leoutsakos JM, Muthen BO, Breitner JC, Lyketsos
CG; For the ADAPT Research Team.Effects of non-steroidal anti-inflammatory
drug treatments on cognitive decline vary by phase of pre-clinical Alzheimer
disease: findings from the randomized controlled Alzheimer's Disease
Anti-inflammatory Prevention Trial. Int J Geriatr Psychiatry. 2012 Apr;27(4):364-374.
6. Mielke MM, Okonkwo OC, Oishi K, Mori S, Tighe
S, Miller MI, Ceritoglu C, Brown T, Albert M, Lyketsos CG. Fornix integrity
and hippocampal volume predict memory decline and progression to Alzheimer's
disease. Alzheimers Dement. 2012 Mar;8(2):105-13. 7. Pirooznia M, Wang T, Avramopoulos D, Valle
D, Thomas G, Huganir RL, Goes FS, Potash JB, Zandi PP. SynaptomeDB:
an ontology-based knowledgebase for synaptic genes. Bioinformatics.
2012 Mar 15;28(6):897-9. 8. Rahn KA, Slusher BS, Kaplin AI. Glutamate in
CNS Neurodegeneration and Cognition and its Regulation by GCPII Inhibition.
Curr Med Chem. 2012 Mar 1;19(9):1335-45. 9. Sheffer CE, Stitzer M, Landes R, Brackman SL,
Munn T, Moore P. Socioeconomic disparities in community-based treatment
of tobacco dependence. Am J Public Health. 2012 Mar;102(3):e8-e16. 10. Shinohara RT, Frangakis CE, Lyketsos CG. A
broad symmetry criterion for nonparametric validity of parametrically
based tests in randomized trials. Biometrics. 2012 Mar;68(1):85-91.
11. Taniguchi Y, Young-Pearse T, Sawa A, Kamiya
A. In utero electroporation as a tool for genetic 12. Testa SM, Krauss GL, Lesser RP, Brandt J.
Stressful life event appraisal and coping in patients with psychogenic
seizures and those with epilepsy. Seizure. 2012 May;21(4):282-7. 13. Unschuld PG, Joel SE, Liu X, Shanahan M, Margolis
RL, Biglan KM, Bassett SS, Schretlen DJ, Redgrave GW, van Zijl PC, Pekar
JJ, Ross CA. Impaired cortico-striatal functional connectivity in prodromal
Huntington's Disease. Neurosci Lett. 2012 Apr 18;514(2):204-9. 14. Willour VL, Seifuddin F, Mahon PB, Jancic
D, Pirooznia M, Steele J, Schweizer B, Goes FS, Mondimore FM, Mackinnon
DF; The Bipolar Genome Study (BiGS) Consortium, Perlis RH, Lee PH, Huang
J, Kelsoe JR, Shilling PD, Rietschel M, Nöthen M, Cichon S, Gurling
H, Purcell S, Smoller JW, Craddock N, Depaulo JR Jr, Schulze TG, McMahon
FJ, Zandi PP, Potash JB. A genome-wide association study of attempted
suicide. Mol Psychiatry. 2012 Apr;17(4):433-444. 1. Chander G, Stanton C, Hutton HE, Abrams DB,
Pearson J, Knowlton A, Latkin C, Holtgrave D, Moore RD, Niaura R. Are
smokers with HIV using information and communication technology? Implications
for behavioral interventions. AIDS Behav. 2012 Feb;16(2):383-8. 2. Kaufmann WE, Tierney E, Rohde CA, Suarez-Pedraza
MC, Clarke MA, Salorio CF, Bibat G, Bukelis I, Naram D, Lanham DC, Naidu
S. Social impairments in Rett syndrome: characteristics and relationship
with clinical severity. J Intellect Disabil Res. 2012 Mar;56(3):233-247.
3. McClure EA, Stitzer ML, Vandrey R. Characterizing
smoking topography of cannabis in heavy users. Psychopharmacology (Berl).
2012 Mar;220(2):309-18. 4. Nestadt G, Di C, Samuels JF, Cheng YJ, Bienvenu
OJ, Reti IM, Costa P, Eaton WW, Bandeen-Roche K. Concordance between
personality disorder assessment methods. Psychol Med. 2012 Mar;42(3):657-67.
5. Peirce JM, Kolodner K, Brooner RK, Kidorf MS.
Traumatic Event Re-exposure in Injecting Drug Users. J 6. Perry-Parrish C, Waasdorp TE, Bradshaw CP.
Peer Nominations of emotional expressivity among urban children: social
and psychological correlates. Soc Dev. 2012 Feb;21(1):88-108. 7. Pogorelov VM, Nomura J, Kim J, Kannan G, Ayhan
Y, Yang C, Taniguchi Y, Abazyan B, Valentine H, Krasnova IN, Kamiya
A, Cadet JL, Wong DF, Pletnikov MV. Mutant DISC1 affects methamphetamine-induced
sensitization and conditioned place preference: a comorbidity model.
Neuropharmacology. 2012 Mar;62(3):1242-51. 8. Rosenblatt A, Kumar BV, Mo A, Welsh CS, Margolis
RL, Ross CA. Age, CAG repeat length, and clinical progression in Huntington's
disease. Mov Disord. 2012 Feb;27(2):272-6. 9. Rudnicki DD, Margolis RL, Pearson CE, Krzyzosiak
WJ. Diced triplets expose neurons to RISC. PLoS Genet. 2012 Feb;8(2):e1002545.
10. Schlund MW, Verduzco G, Cataldo MF, Hoehn-Saric
R. Generalized anxiety modulates frontal and limbic activation in major
depression. Behav Brain Funct. 2012 Feb 9;8:8. 11. Seixas AI, Holmes SE, Takeshima H, Pavlovich
A, Sachs N, Pruitt JL, Silveira I, Ross CA, Margolis RL, Rudnicki DD.
Loss of junctophilin-3 contributes to huntington disease-like 2 pathogenesis.
Ann Neurol. 2012 Feb;71(2):245-57. 12. Sheffer CE, Stitzer M, Landes R, Brackman
SL, Munn T, Moore P. Socioeconomic disparities in community-based treatment
of tobacco dependence. Am J Public Health. 2012 Mar; 102(3):e8-e16.
13. Vaidya PV, Anderson EL, Bobb A, Pulia K, Jayaram
G, Reti I. A within-subject comparison of propofol and methohexital
anesthesia for electroconvulsive therapy. J ECT. 2012 Mar;28(1):14-9.
14. Xiao J, Kannan G, Jones-Brando L, Brannock
C, Krasnova IN, Cadet JL, Pletnikov M, Yolken RH. Sex-specific changes
in gene expression and behavior induced by chronic Toxoplasma infection
in mice. Neuroscience. 2012 Mar 29;206:39-48. 1. Affrunti NW, Ginsburg GS. Maternal overcontrol
and child anxiety: the mediating role of perceived competence. Child
Psychiatry Hum Dev. 2012 Feb; 43(1):102-12. 2. Davidson JE, Jones C, Bienvenu OJ. Family response
to critical illness: Postintensive care syndrome-family. Crit Care Med.
2012 Feb;40(2):618-24. 3. DeFulio A, Everly JJ, Leoutsakos JM, Umbricht
A, Fingerhood M, Bigelow GE, Silverman K. Employment-based reinforcement
of adherence to an FDA approved extended release formulation of naltrexone
in opioid-dependent adults: a randomized controlled trial. Drug Alcohol
Depend. 2012 Jan 1;120(1-3):48-54. 4. Goodin BR, Quinn NB, Kronfli T, King CD, Page
GG, Haythornthwaite JA, Edwards RR, Stapleton LM, McGuire L. Experimental
pain ratings and reactivity of cortisol and soluble tumor necrosis factor-?
receptor II following a trial of hypnosis: results of a randomized controlled
pilot study. Pain Med. 2012 Jan;13(1):29-44. 5. Ladenheim EE. Gastrointestinal regulatory peptides
and central nervous system mechanisms of weight control. Curr Opin Endocrinol
Diabetes Obes. 2012 Feb;19(1):13-8. 6. Lyketsos CG, Miller DS; Neuropsychiatric Syndromes
Professional Interest Area of the International Society to Advance Alzheimer's
Research and Treatment. Addressing the Alzheimer's disease crisis through
better understanding, treatment, and eventual prevention of associated
neuropsychiatric syndromes. Alzheimers Dement. 2012 Jan;8(1):60-4. 7. Needham DM, Davidson J, Cohen H, Hopkins RO,
Weinert C, Wunsch H, Zawistowski C, Bemis-Dougherty A, Berney SC, Bienvenu
OJ, Brady SL, Brodsky MB, Denehy L, Elliott D, Flatley C, Harabin AL,
Jones C, Louis D, Meltzer W, Muldoon SR, Palmer JB, Perme C, Robinson
M, Schmidt DM, Scruth E, Spill GR, Storey CP, Render M, Votto J, Harvey
MA. Improving long-term outcomes after discharge from intensive care
unit: Report from a stakeholders' conference*. Crit Care Med. 2012 Feb;40(2):502-509.
8. Schindler CW, Goldberg SR. Accelerating cocaine
metabolism as an approach to the treatment of cocaine abuse and toxicity.
Future Med Chem. 2012 Feb;4(2):163-75. 9. Waasdorp TE, Bradshaw CP, Leaf PJ. The impact
of schoolwide positive behavioral interventions and supports on bullying
and peer rejection: a randomized controlled effectiveness trial. Arch
Pediatr Adolesc Med. 2012 Feb;166(2):149-56. 1. Angelino A, Lyketsos CG. Training in psychosomatic
medicine: a psychiatric subspecialty recognized in the United States
by the American board of medical specialties. J Psychosom Res. 2011
Dec;71(6):431-2. 2. Bang S, Kim S, Dailey MJ, Chen Y, Moran TH,
Snyder SH, Kim SF. AMP-activated protein kinase is physiologically regulated
by inositol polyphosphate multikinase. Proc Natl Acad Sci U S A. 2012
Jan 10;109(2):616-20. 3. Bienvenu OJ, Samuels JF, Wuyek LA, Liang KY,
Wang Y, Grados MA, Cullen BA, Riddle MA, Greenberg BD, Rasmussen SA,
Fyer AJ, Pinto A, Rauch SL, Pauls DL, McCracken JT, Piacentini J, Murphy
DL, Knowles JA, Nestadt G. Is obsessive-compulsive disorder an anxiety
disorder, and what, if any, are spectrum conditions? A family study
perspective. Psychol Med. 2012 Jan;42(1):1-13. 4. Blom RM, Samuels JF, Grados MA, Chen Y, Bienvenu
OJ, Riddle MA, Liang KY, Brandt J, Nestadt G. Cognitive functioning
in compulsive hoarding. J Anxiety Disord. 2011 Dec;25(8):1139-44. 5. Coughlin JW, Schreyer CC, Sarwer DB, Heinberg
LJ, Redgrave GW, Guarda AS. Cosmetic surgery in inpatients with eating
disorders: Attitudes and experience. Body Image. 2012 Jan;9(1):180-3.
6. Dailey MJ, Stingl KC, Moran TH. Disassociation
between Preprandial Gut Peptide Release and Food-Anticipatory Activity.
Endocrinology. 2012 Jan;153(1):132-42. 7. Defulio A, Everly JJ, Leoutsakos JM, Umbricht
A, Fingerhood M, Bigelow GE, Silverman K. Employment-based reinforcement
of adherence to an FDA approved extended release formulation of naltrexone
in opioid-dependent adults: A randomized controlled trial. Drug Alcohol
Depend. 2012 Jan 1;120(1-3):48-54. 8. Goodin BR, Quinn NB, King CD, Page GG, Haythornthwaite
JA, Edwards RR, Stapleton L, McGuire L. Salivary cortisol and soluble
tumor necrosis factor-? receptor II responses to multiple experimental
modalities of acute pain. Psychophysiology. 2012 Jan;49(1):118-127.
9. Jiang M, Wang J, Fu J, Du L, Jeong H, West
T, Xiang L, Peng Q, Hou Z, Cai H, Seredenina T, Arbez N, Zhu S, Sommers
K, Qian J, Zhang J, Mori S, Yang XW, Tamashiro KL, Aja S, Moran TH,
Luthi-Carter R, Martin B, Maudsley S, Mattson MP, Cichewicz RH, Ross
CA, Holtzman DM, Krainc D, Duan W. Neuroprotective role of Sirt1 in
mammalian models of Huntington's disease through activation of multiple
Sirt1 targets. Nat Med. 2011 Dec 18;18(1):153-8. 10. Judy JT, Seifuddin F, Mahon PB, Huo Y, Goes
FS, Jancic D, Schweizer B, Mondimore FM, Mackinnon DF, Depaulo JR Jr,
Gershon ES, McMahon FJ, Cutler DJ, Zandi PP, Potash JB, Willour VL.
Association study of serotonin pathway genes in attempted suicide. Am
J Med Genet B Neuropsychiatr Genet. 2012 Jan;159B(1):112-9. 11. Lin CY, Sawa A, Jaaro-Peled H. Better understanding
of mechanisms of schizophrenia and bipolar disorder: from human gene
expression profiles to mouse models. Neurobiol Dis. 2012 Jan;45(1):48-56.
12. Mahone EM. ADHD: Volumetry, Motor, and Oculomotor
Functions. Curr Top Behav Neurosci. 2012;9:17-47. 13. Nestadt G, Wang Y, Grados MA, Riddle MA, Greenberg
BD, Knowles JA, Fyer AJ, McCracken JT, Rauch SL, Murphy DL, Rasmussen
SA, Cullen B, Piacentini J, Geller D, Pauls D, Bienvenu OJ, Chen Y,
Liang KY, Goes FS, Maher B, Pulver AE, Shugart YY, Valle D, Samuels
JF, Chang YC. Homeobox genes in obsessive-compulsive disorder. Am J
Med Genet B Neuropsychiatr Genet. 2012 Jan;159B(1):53-60. 14. Vandrey R, Dunn KE, Fry JA, Girling ER. A
survey study to characterize use of Spice products (synthetic cannabinoids).
Drug Alcohol Depend. 2012 Jan 1;120(1-3):238-41 15. Waldron-Roby E, Ratovitski T, Wang X, Jiang
M, Watkin E, Arbez N, Graham RK, Hayden MR, Hou Z, Mori S, Swing D,
Pletnikov M, Duan W, Tessarollo L, Ross CA. Transgenic mouse model expressing
the caspase 6 FRAGMENT OF MUTANT Huntingtin. J Neurosci. 2012 Jan 4;32(1):183-193. 1. Appel LJ, Clark JM, Yeh HC, Wang NY, Coughlin
JW, Daumit G, Miller ER 3rd, Dalcin A, Jerome GJ, Geller S, Noronha
G, Pozefsky T, Charleston J, Reynolds JB, Durkin N, Rubin RR, Louis
TA, Brancati FL. Comparative effectiveness of weight-loss interventions
in clinical practice. N Engl J Med. 2011 Nov 24;365(21):1959-68. 2. Bittner AK, Ibrahim MA, Haythornthwaite JA,
Diener-West M, Dagnelie G. Vision test variability in retinitis pigmentosa
and psychosocial factors. Optom Vis Sci. 2011 Dec;88(12):1496-506. 3. Blom RM, Samuels JF, Grados MA, Chen Y, Bienvenu
OJ, Riddle MA, Liang KY, Brandt J, Nestadt G. Cognitive functioning
in compulsive hoarding. J Anxiety Disord. 2011 Dec;25(8):1139-44. 4. Cascella NG, Gerner GJ, Fieldstone SC, Sawa
A, Schretlen DJ. The insula-claustrum region and delusions in schizophrenia.
Schizophr Res. 2011 Dec; 133(1-3):77-81. 5. Dailey MJ, Moghadam AA, Moran TH. Jejunal linoleic
acid infusions require GLP-1 receptor signaling to inhibit food intake:
implications for the effectiveness of Roux-en-Y gastric bypass. Am J
Physiol Endocrinol Metab. 2011 Dec; 301(6):E1184-90. 6. Ginsburg GS, Kendall PC, Sakolsky D, Compton
SN, Piacentini J, Albano AM, Walkup JT, Sherrill J, Coffey KA, Rynn
MA, Keeton CP, McCracken JT, Bergman L, Iyengar S, Birmaher B, March
J. Remission after acute treatment in children and adolescents with
anxiety disorders: Findings from the CAMS. J Consult Clin Psychol. 2011
Dec; 79(6):806-13. 7. Griffiths RR, Johnson MW, Richards WA, Richards
BD, McCann U, Jesse R. Psilocybin occasioned mystical-type experiences:
immediate and persisting dose-related effects. Psychopharmacology (Berl).
2011 Dec; 218(4):649-65. 8. Kidorf M, King VL, Peirce J, Kolodner K, Brooner
RK. A treatment reengagement intervention for syringe exchangers. J
Subst Abuse Treat. 2011 Dec;41(4):415-21. 9. Kondo M, Sawa A. Anti-/Propsychotic Drug Signaling
via Heteromeric GPCRs-A Balancing Act? Cell. 2011 Nov 23;147(5):964-5.
10. Kurtz PF, Boelter EW, Jarmolowicz DP, Chin
MD, Hagopian LP. An analysis of functional communication training as
an empirically supported treatment for problem behavior displayed by
individuals with intellectual disabilities. Res Dev Disabil. 2011 Nov;32(6):2935-42.
11. Mustafa AK, Sikka G, Gazi SK, Steppan J, Jung
SM, Bhunia AK, Barodka VM, Gazi FK, Barrow RK, Wang R, Amzel LM, Berkowitz
DE, Snyder SH. Hydrogen sulfide as endothelium-derived hyperpolarizing
factor sulfhydrates potassium channels. Circ Res. 2011 Nov 11;109(11):1259-68.
12. Neufeld KJ, Joseph Bienvenu O, Rosenberg PB,
Mears SC, Lee HB, Kamdar BB, Sieber FE, Krumm SK, Walston JD, Hager
DN, Touradji P, Needham DM. The Johns Hopkins Delirium Consortium: a
model for collaborating across disciplines and departments for delirium
prevention and treatment. J Am Geriatr Soc. 2011 Nov;59 Suppl 2:S244-8.
13. Smith GS, Kahn A, Sacher J, Rusjan P, van
Eimeren T, Flint A, Wilson AA. Serotonin Transporter Occupancy and the
Functional Neuroanatomic Effects of Citalopram in Geriatric Depression.
Am J Geriatr Psychiatry. 2011 Dec;19(12):1016-1025. 14. Snyder SH. What dopamine does in the brain.
Proc Natl Acad Sci U S A. 2011 Nov 22;108(47): 15. Weerts EM, Wand GS, Kuwabara H, Munro CA,
Dannals RF, Hilton J, Frost JJ, McCaul ME. Positron Emission Tomography
Imaging of Mu- and Delta-Opioid Receptor Binding in Alcohol-Dependent
and Healthy Control Subjects. Alcohol Clin Exp Res. 2011 Dec;35(12):2162-2173.
1. Duff K, Lyketsos
CG, Beglinger LJ, Chelune G, Moser DJ, Arndt S, Schultz SK, Paulsen
JS, Petersen RC, McCaffrey RJ. Practice effects predict cognitive outcome
in amnestic mild cognitive impairment. Am J Geriatr Psychiatry. 2011
Nov;19(11):932-9. 2. Hagopian LP, Rooker GW, Rolider NU. Identifying
empirically supported treatments for pica in individuals with intellectual
disabilities. Res Dev Disabil. 2011 Nov;32(6):2114-20. 3. Kano S, Nwulia E, Niwa M, Chen Y, Sawa A, Cascella
N. Altered MHC class I expression in dorsolateral prefrontal cortex
of nonsmoker patients with schizophrenia. Neurosci Res. 2011 Nov;71(3):289-93.
4. Lee RS, Tamashiro KL, Yang X, Purcell RH, Huo
Y, Rongione M, Potash JB, Wand GS. A measure of glucocorticoid load
provided by DNA methylation of Fkbp5 in mice. Psychopharmacology (Berl).
2011 Nov;218(1):303-12. 5. Moran TH, Dailey MJ. Intestinal feedback signaling
and satiety. Physiol Behav. 2011 Nov 30;105(1):77-81 6. Wand GS, Weerts EM, Kuwabara H, Frost JJ, Xu
X, McCaul ME. Naloxone-induced cortisol predicts mu opioid receptor
binding potential in specific brain regions of healthy subjects. Psychoneuroendocrinology.
2011 Nov;36(10):1453-9. 1. Chung DW, Rudnicki
DD, Yu L, Margolis RL. A natural antisense transcript at the Huntington's
disease repeat locus regulates HTT expression. Hum Mol Genet. 2011 Sep
1;20(17):3467-77. 2. Concheiro M, Jones HE, Johnson RE, Choo R,
Huestis MA. Preliminary buprenorphine sublingual tablet pharmacokinetic
data in plasma, oral fluid, and sweat during treatment of opioid-dependent
pregnant women. Ther Drug Monit. 2011 Oct;33(5):619-26. 3. Hennelly M, Yi J, Batkis M, Chisolm MS. Termination
of pregnancy in two patients during psychiatric hospitalization for
depressive symptoms and substance dependence. Psychosomatics. 2011 Sep-Oct;52(5):482-5.
4. Maroof DA, Gross AL, Brandt J. Modeling longitudinal
change in motor and cognitive processing speed in presymptomatic Huntington's
disease. J Clin Exp Neuropsychol. 2011 Oct;33(8):901-9. 5. McCann UD, Edwards RR, Smith MT, Kelley K,
Wilson M, Sgambati F, Ricaurte G. Altered pain responses in abstinent
(±)3,4-methylenedioxymethamphetamine (MDMA, "ecstasy")
users. Psychopharmacology (Berl). 2011 Oct;217(4):475-84. 6. Nucifora FC Jr, Hall RC, Everly GS Jr. Reexamining
the role of the traumatic stressor and the trajectory of posttraumatic
distress in the wake of disaster. Disaster Med Public Health Prep. 2011
Sep;5 Suppl 2:S172-5. 1. Blom RM, Samuels
JF, Riddle MA, Joseph Bienvenu O, Grados MA, Reti IM, EatonWW, Liang
KY, Nestadt G. Association between a serotonin transporter promoter
polymorphism (5HTTLPR) and personality disorder traits in a community
sample. J Psychiatr Res. 2011 Sep;45(9):1153-9. 2. Bruce ML, Bartels SJ, Lyness JM, Sirey JA,
Sheline YI, Smith G. Promoting the transition to independent scientist:
a national career development program. Acad Med. 2011 Sep;86(9):1179-1184.
3. Daumit GL, Dalcin AT, Jerome GJ, Young DR,
Charleston J, Crum RM, Anthony C, Hayes JH, McCarron PB, Khaykin E,
Appel LJ. A behavioral weight-loss intervention for persons with serious
mental illness in psychiatric rehabilitation centers. Int J Obes (Lond).
2011 Aug;35(8):1114-23. 4. de Medeiros K, Mosby A, Hanley KB, Pedraza
MS, Brandt J. A randomized clinical trial of a writing workshop intervention
to improve autobiographical memory and well-being in older adults. Int
J Geriatr Psychiatry. 2011 Aug;26(8):803-11. 5. Eze-Nliam CM, Quartana PJ, Quain AM, Smith
MT. Nocturnal heart rate variability is lower in temporomandibular disorder
patients than in healthy, pain-free individuals. J Orofac Pain. 2011
Summer;25(3):232-9. 6. Larson JJ, Yoon Y, Stewart M, dosReis S. Influence
of caregivers' experiences on service use among children with attention-deficit
hyperactivity disorder. Psychiatr Serv. 2011 Jul;62(7):734-9. 7. Lyketsos CG, Carrillo MC, Ryan JM, Khachaturian
AS, Trzepacz P, Amatniek J, Cedarbaum J, Brashear R, Miller DS. Neuropsychiatric
symptoms in Alzheimer's disease. Alzheimers Dement. 2011 Sep;7(5):532-9.
8. Mostofsky SH, Ewen JB. Altered connectivity
and action model formation in autism is autism. Neuroscientist. 2011
Aug;17(4):437-48. 9. Norton MC, Smith KR, Ostbye T, Tschanz JT,
Schwartz S, Corcoran C, Breitner JC, Steffens DC, Skoog I, Rabins PV,
Welsh-Bohmer KA; For the Cache County Investigators. Early parental
death and remarriage of widowed parents as risk factors for Alzheimer
Disease: The Cache County Study. Am J Geriatr Psychiatry.2011 Sep;19(9):814-824.
10. Purcell RH, Sun B, Pass LL, Power ML, Moran
TH, Tamashiro KL. Maternal stress and high-fat diet effect on maternal
behavior, milk composition, and pup ingestive behavior. Physiol Behav.
2011 Sep 1;104(3):474-9. 11. Rosenblatt A, Kumar BV, Margolis RL, Welsh
CS, Ross CA. Factors contributing to institutionalization in patients
with Huntington's disease. Mov Disord. 2011Aug 1;26(9):1711-6. 12. Salami O, Lyketsos C, Rao V. Treatment of
sleep disturbance in Alzheimer's dementia. Int J Geriatr Psychiatry.
2011 Aug;26(8):771-82. 13. Tamashiro KL, Sakai RR, Shively CA, Karatsoreos
IN, Reagan LP. Chronic stress, metabolism, and metabolic syndrome. Stress.
2011 Sep;14(5):468-74. 14. Tamashiro KL. Metabolic syndrome: links to
social stress and socioeconomic status. Ann N Y Acad Sci. 2011 Aug;1231(1):46-55.
15. Vandrey R, Smith MT, McCann UD, Budney AJ,
Curran EM. Sleep disturbance and the effects of extended-release zolpidem
during cannabis withdrawal. Drug Alcohol Depend. 2011 Aug 1;117(1):38-44.
16. Watkins CC, Pieper AA, Treisman GJ.
Safety considerations in drug treatment of depression in HIV-positive
patients: an updated review. Drug Saf. 2011 Aug 1;34(8):623-39. 1. Bellin MH, Dicianno
BE, Levey E, Dosa N, Roux G, Marben K, Zabel TA. Interrelationships
of sex, level of lesion, and transition outcomes among young adults
with myelomeningocele. Dev Med Child Neurol. 2011 Jul;53(7):647-652.
2. Campbell CM, Bounds
SC, Simango MB, Witmer KR, Campbell JN, Edwards RR, Haythornthwaite
JA, Smith MT. Self-reported sleep duration associated with distraction
analgesia, hyperemia, and secondary hyperalgesia in the heat-capsaicin
nociceptive model. Eur J Pain. 2011 Jul;15(6):561-7. 3. Chao PT, Terrillion
CE, Moran TH, Bi S. High-fat diet offsets the long-lasting effects of
running-wheel access on food intake and body weight in OLETF rats. Am
J Physiol Regul Integr Comp Physiol. 2011 Jun;300(6):R1459-67. 4. Duke AN, Bigelow
GE, Lanier RK, Strain EC. Discriminative stimulus effects of tramadol
in humans. J Pharmacol Exp Ther. 2011 Jul;338(1):255-62. 5. Everly GS Jr, Davy
JA, Smith KJ, Lating JM, Nucifora FC Jr. A defining aspect of human
resilience in the workplace: a structural modeling approach. Disaster
Med Public Health Prep. 2011 Jun;5(2):98-105. 6. Goodin BR, Fillingim
RB, Machala S, McGuire L, Buenaver LF, Campbell CM, Smith MT. Subjective
sleep quality and ethnicity are interactively related to standard and
situation-specific measures of pain catastrophizing. Pain Med. 2011
Jun;12(6):913-22. 7. Horwitz SM, Heinberg
LJ, Storfer-Isser A, Barnes DH, Smith M, Kapur R, Findling R, Currier
G, Wilcox HC, Wilkens K. Teaching Physicians to Assess Suicidal Youth
Presenting to the Emergency Department. Pediatr Emerg Care. 2011Jul;27(7):601-605.
8. Howell PC, Larson
J, Coffey DB. Treatment of bipolar disorder in an adolescent with autistic
disorder: a diagnostic and treatment dilemma. J Child Adolesc Psychopharmacol.
2011 Jun;21(3):283-6. 9. Koga M, Serritella
AV, Messmer MM, Hayashi-Takagi A, Hester LD, Snyder SH, Sawa A, Sedlak
TW. Glutathione is a physiologic reservoir of neuronal glutamate. Biochem
Biophys Res Commun. 2011 Jun 17;409(4):596-602. 10. Liu CC, Wissow
L. How post-call resident doctors perform, feel and are perceived in
out-patient clinics. Med Educ. 2011 Jul;45(7):669-77. 11. Neufeld KJ, Schuckit
MA, Hernandez-Avila CA. Alcohol medical scholars program-a mentorship
program for improving medical education regarding substance use disorders.
Subst Abus. 2011 Jul;32(3):121-7. 12. Spinelli S, Vasa
RA, Joel S, Nelson TE, Pekar JJ, Mostofsky SH. Variability in post-error
behavioral adjustment is associated with functional abnormalities in
the temporal cortex in children with ADHD. J Child Psychol Psychiatry.
2011 Jul;52(7):808-16. 13. Stefanis NC, Mandelli
L, Hatzimanolis A, Zaninotto L, Smyrnis N, Avramopoulos D, Evdokimidis
I, Serretti A. Serotonin transporter gene variants and prediction of
stress-induced risk for psychological distress. Genes Brain Behav. 2011
Jul;10(5):536-41. 14. Wang Y, Steimle
PA, Ren Y, Ross CA, Robinson DN, Egelhoff TT, Sesaki H, Iijima M. Dictyostelium
huntingtin controls chemotaxis and cytokinesis through the regulation
of myosin II phosphorylation. Mol Biol Cell. 2011 Jul;22(13):2270-81.
15. Xiang Z, Valenza
M, Cui L, Leoni V, Jeong HK, Brilli E, Zhang J, Peng Q, Duan W, Reeves
SA, Cattaneo E, Krainc D. Peroxisome-Proliferator-Activated Receptor
Gamma Coactivator 1 {alpha} Contributes to Dysmyelination in Experimental
Models of Huntington's Disease. J Neurosci. 2011 Jun 29;31(26):9544-9553.
1. Amoyal NR, Mason
ST, Gould NF, Corry N, Mahfouz S, Barkey A, Fauerbach JA. Measuring
coping behavior in patients with major burn injuries: a psychometric
evaluation of the BCOPE. J Burn Care Res. 2011 May-Jun;32(3):392-8.
2. Aylward E, Mills
J, Liu D, Nopoulos P, Ross CA, Pierson R, Paulsen JS. Association between
age and striatal volume stratified by CAG repeat length in prodromal
Huntington Disease. PLoS Curr. 2011 May 11;3:RRN1235. 3. Becker KD, Ginsburg GS. Maternal anxiety,
behaviors, and expectations during a behavioral task: relation to children's
self-evaluations. Child Psychiatry Hum Dev. 2011 Jun;42(3):320-33. 4. Cheng Y, Peng Q, Hou Z, Aggarwal M, Zhang
J, Mori S, Ross CA, Duan W. Structural MRI detects progressive regional
brain atrophy and neuroprotective effects in N171-82Q Huntington's disease
mouse model. Neuroimage. 2011 Jun 1;56(3):1027-34. 5. Edwards RR, Quartana PJ, Allen RP, Greenbaum
S, Earley CJ, Smith MT. Alterations in pain responses in treated and
untreated patients with restless legs syndrome: Associations with sleep
disruption. Sleep Med. 2011 Jun;12(6):603-9. 6. Everly JJ, Defulio A, Koffarnus MN, Leoutsakos
JM, Donlin WD, Aklin WM,Umbricht A, Fingerhood M, Bigelow GE, Silverman
K. Employment-based reinforcementof adherence to depot naltrexone in
unemployed opioid-dependent adults: arandomized controlled trial. Addiction.
2011 Jul;106(7):1309-18. 7. Festa CC, Ginsburg GS. Parental and peer
predictors of social anxiety in youth. Child Psychiatry Hum Dev. 2011
Jun;42(3):291-306. 8. Goes FS, Rongione M, Chen YC, Karchin
R, Elhaik E; the Bipolar Genome Study, Potash JB. Exonic DNA Sequencing
of ERBB4 in Bipolar Disorder. PLoS One. 2011;6(5):e20242. 9. Koliatsos VE, Cernak I, Xu L, Song Y,
Savonenko A, Crain BJ, Eberhart CG,Frangakis CE, Melnikova T, Kim H,
Lee D. A mouse model of blast injury to brain: initial pathological,
neuropathological, and behavioral characterization. J Neuropathol Exp
Neurol. 2011 May;70(5):399-416. 10. Nowrangi MA, Rao V, Lyketsos CG. Epidemiology,
assessment, and treatment of dementia. Psychiatr Clin North Am. 2011
Jun;34(2):275-94. 11. Rabins PV, Kass NE, Rutkow L, Vernick
JS, Hodge JG. Challenges for mental health services raised by disaster
preparedness: mapping the ethical and therapeutic terrain. Biosecur
Bioterror. 2011 Jun;9(2):175-179. 12. Samuels J, Wang Y, Riddle MA, Greenberg
BD, Fyer AJ, McCracken JT, Rauch SL, Murphy DL, Grados MA, Knowles JA,
Piacentini J, Cullen B, Bienvenu OJ 3rd, Rasmussen SA, Geller D, Pauls
DL, Liang KY, Shugart YY, Nestadt G. Comprehensive family-based association
study of the glutamate transporter gene SLC1A1 in obsessive-compulsive
disorder. Am J Med Genet B Neuropsychiatr Genet. 2011 Jun;156(4):472-7.
13. Sojkova J, Zhou Y, An Y, Kraut MA, Ferrucci
L, Wong DF, Resnick SM. Longitudinal patterns of {beta}-amyloid deposition
in nondemented older adults. Arch Neurol. 2011 May;68(5):644-9. 14. Tschanz JT, Corcoran CD, Schwartz S,
Treiber K, Green RC, Norton MC, Mielke MM, Piercy K, Steinberg M, Rabins
PV, Leoutsakos JM, Welsh-Bohmer KA, Breitner JC, Lyketsos CG. Progression
of cognitive, functional, and neuropsychiatric symptom domains in a
population cohort with Alzheimer dementia: The Cache County Dementia
Progression Study. Am J Geriatr Psychiatry. 2011 Jun;19(6):532-542. 15. Zoubovsky SP, Pogorelov VM, Taniguchi
Y, Kim SH, Yoon P, Nwulia E, Sawa A, Pletnikov MV, Kamiya A. Working
memory deficits in neuronal nitric oxide synthase knockout mice: Potential
impairments in prefrontal cortex mediated cognitive function. Biochem
Biophys Res Commun. 2011 May 20;408(4):707-12. 1. Allman MJ, Deleon IG, Wearden JH. Psychophysical
assessment of timing in individuals with autism. Am J Intellect Dev
Disabil. 2011 Mar;116(2):165-78. 2. Chao PT, Yang L, Aja S, Moran TH, Bi S. Knockdown
of NPY Expression in the Dorsomedial Hypothalamus Promotes Development
of Brown Adipocytes and Prevents Diet-Induced Obesity. Cell Metab. 2011
May 4;13(5):573-83. 3. Clark MR, Treisman GJ. Optimizing treatment
with opioids and beyond. Adv Psychosom Med. 2011;30: 92-112. 4. Clark MR, Treisman GJ. From stigmatized neglect
to active engagement. Adv Psychosom Med. 2011;30: 1-7. 5. Gray TR, Dams R, Choo RE, Jones HE, Huestis
MA. Methadone disposition in oral fluid during pharmacotherapy for opioid-dependence.
Forensic Sci Int. 2011 Mar 20;206(1-3):98-102. 6. Gould NF, McKibben JB, Hall R, Corry NH, Amoyal
NA, Mason ST, McCann UD, Fauerbach JA. Peritraumatic heart rate and
posttraumatic stress disorder in patients with severe burns. J Clin
Psychiatry. 2011 Apr;72(4):539-47. 7. Ishizuka K, Kamiya A, Oh EC, Kanki H, Seshadri
S, Robinson JF, Murdoch H, Dunlop AJ, Kubo K, Furukori K, Huang B, Zeledon
M, Hayashi-Takagi A, Okano H, Nakajima K, Houslay MD, Katsanis N, Sawa
A. DISC1-dependent switch from progenitor proliferation to migration
in the developing cortex. Nature. 2011 May 5;473(7345):92-6. 8. Johnson MW, Maclean KA, Reissig CJ, Prisinzano
TE, Griffiths RR. Human psychopharmacology and dose-effects of salvinorin
A, a kappa opioid agonist hallucinogen present in the plant Salvia divinorum.
Drug Alcohol Depend. 2011 May 1;115(1-2):150-5. 9. Jones HE, O'Grady KE, Tuten M. Reinforcement-based
treatment improves the maternal treatment and neonatal outcomes of pregnant
patients enrolled in comprehensive care treatment. Am J Addict. 2011
May;20 (3):196-204. 10. Jones HE, Tuten M, O'Grady KE. Treating the
partners of opioid-dependent pregnant patients: feasibility and efficacy.
Am J Drug Alcohol Abuse. 2011 May;37(3):170-8. 11. Kidorf M, King VL, Pierce J, Kolodner K, Brooner
RK. Benefits of concurrent syringe exchange and substance abuse treatment
participation. J Subst Abuse Treat. 2011 Apr;40(3):265-71. 12. Moran TH, Ladenheim EE. Adiposity signaling
and meal size control. Physiol Behav. 2011 Apr 18;103(1):21-4. 13. Pontone GM, Williams JR, Anderson KE, Chase
G, Goldstein SR, Grill S, Hirsch ES, Lehmann S, Little JT, Margolis
RL, Rabins PV, Weiss HD, Marsh L. Anxiety and self-perceived health
status in Parkinson's disease. Parkinsonism Relat Disord. 2011 May;17(4):249-54.
14. Shahani N, Sawa A. Nitric oxide signaling
and nitrosative stress in neurons: role for s-nitrosylation. Antioxid
Redox Signal. 2011 Apr 15;14(8):1493-504. 15. Treisman GJ, Clark MR. A behaviorist perspective.
Adv Psychosom Med. 2011;30:8-21. 1. Belmonte Mahon P,
Pirooznia M, Goes FS, Seifuddin F, Steele J, Lee PH, Huang J, Hamshere
ML; The Bipolar Genome Study (BiGS) Consortium, The Wellcome Trust Case
Control Consortium Bipolar Disorder Group, Depaulo JR Jr, Kelsoe JR,
Rietschel M, Nöthen M, Cichon S, Gurling H, Purcell S, Smoller
JW, Craddock N, Schulze TG, McMahon FJ, Potash JB, Zandi PP. Genome-wide
association analysis of age at onset and psychotic symptoms in bipolar
disorder. Am J Med Genet B Neuropsychiatr Genet. 2011 Apr;156(3):370-378 2. Carroll CP, Haythornthwaite
J. Maladaptive opioid use behaviors and psychiatric illness: what should
we do with what we know? Curr Pain Headache Rep. 2011 Apr;15(2):91-3.
3. Clark MR. Chronic
opioid therapy for chronic pain: an e-learning program to develop shared
decision-making and communication skills. Curr Pain Headache Rep. 2011
Apr;15(2):88-90. 4. Fallin MD, Lasseter
VK, Liu Y, Avramopoulos D, McGrath J, Wolyniec PS, Nestadt G, Liang
KY, Chen PL, Valle D, Pulver AE. Linkage and association on 8p21.2-p21.1
in schizophrenia. Am J Med Genet B Neuropsychiatr Genet. 2011 Mar;156(2):188-97.
5. Goodwin AK, Kaminski
BJ, Griffiths RR, Ator NA, Weerts EM. Intravenous self-administration
of gamma-hydroxybutyrate (GHB) in baboons. Drug Alcohol Depend. 2011
Apr 1;114(2-3):217-24. 6. Hutton HE, Wilson
LM, Apelberg BJ, Avila Tang E, Odelola O, Bass EB, Chander G. A systematic
review of randomized controlled trials: web-based interventions for
smoking cessation among adolescents, college students, and adults. Nicotine
Tob Res. 2011 Apr;13(4):227-38. 7. Jayaram G, Doyle D, Steinwachs D, Samuels J.
Identifying and reducing medication errors in psychiatry: creating a
culture of safety through the use of an adverse event reporting mechanism.
J Psychiatr Pract. 2011 Mar;17(2):81-8. 8. Johnston D, Samus QM, Morrison A, Leoutsakos
JS, Hicks K, Handel S, Rye R, Robbins B, Rabins PV, Lyketsos CG, Black
BS. Identification of community-residing individuals with dementia and
their unmet needs for care. Int J Geriatr Psychiatry. 2011 Mar;26(3):292-8.
9. Leoutsakos JM, Bandeen-Roche K, Garrett-Mayer
E, Zandi PP. Incorporating scientific knowledge into phenotype development:
Penalized latent class regression. Stat Med. 2011 Mar 30;30(7):784-98.
doi: 10.1002/sim.4137. 10. Mejias R, Adamczyk A, Anggono V, Niranjan
T, Thomas GM, Sharma K, Skinner C, Schwartz CE, Stevenson RE, Fallin
MD, Kaufmann W, Pletnikov M, Valle D, Huganir RL, Wang T. Gain-of-function
glutamate receptor interacting protein 1 variants alter GluA2 recycling
and surface distribution in patients with autism. Proc Natl Acad Sci
U S A. 2011 Mar 22;108(12):4920-5. 11. Mroczkowski MM, Goes FS, Riddle MA, Grados
MA, Joseph Bienvenu O 3rd, Greenberg BD, Fyer AJ, McCracken JT, Rauch
SL, Murphy DL, Knowles JA, Piacentini J, Cullen B, Rasmussen SA, Geller
DA, Pauls DL, Liang KY, Nestadt G, Samuels JF. Separation anxiety disorder
in OCD. Depress Anxiety. 2011 Mar;28(3):256-62. 12. Mroczkowski MM, Redgrave GW, Miller NR, McCoy
AN, Guarda AS. Reversible vision loss secondary to malnutrition in a
woman with severe anorexia nervosa, purging type, and alcohol abuse.
Int J Eat Disord. 2011 Apr;44(3):281-3. 13. Neufeld KJ, Hayat MJ, Coughlin JM, Huberman
AL, Leistikow NA, Krumm SK, Needham DM. Evaluation of Two Intensive
Care Delirium Screening Tools for Non-Critically Ill Hospitalized Patients.
Psychosomatics. 2011 March - April;52(2):133-140. 14. Rosenberg PB, Mielke MM, Appleby B, Oh E,
Leoutsakos JM, Lyketsos CG. Neuropsychiatric symptoms in MCI subtypes:
the importance of executive dysfunction. Int J Geriatr Psychiatry. 2011
Apr;26(4):364-72. 15. Tompkins DA, Campbell CM. Opioid-induced hyperalgesia:
clinically relevant or extraneous research phenomenon? Curr Pain Headache
Rep. 2011 Apr;15(2):129-36. 1. Aretouli E, Okonkwo OC, Samek J, Brandt J.
The fate of the 0.5s: predictors of 2-year outcome in mild cognitive
impairment. J Int Neuropsychol Soc. 2011 Mar;17(2):277-88. 2. Ayhan Y, Abazyan B, Nomura J, Kim R, Ladenheim
B, Krasnova IN, Sawa A, Margolis RL, Cadet JL, Mori S, Vogel MW, Ross
CA, Pletnikov MV. Differential effects of prenatal and postnatal expressions
of mutant human DISC1 on neurobehavioral phenotypes in transgenic mice:
evidence for neurodevelopmental origin of major psychiatric disorders.
Mol Psychiatry. 2011 Mar;16(3):293-306. 3. Johnston D, Samus QM, Morrison A, Leoutsakos
JS, Hicks K, Handel S, Rye R, Robbins B, Rabins PV, Lyketsos CG, Black
BS. Identification of community-residing individuals with dementia and
their unmet needs for care. Int J Geriatr Psychiatry. 2011 Mar;26(3):292-8.
4. Murinson BB, Nenortas E, Mayer RS, Mezei L,
Kozachik S, Nesbit S, Haythornthwaite JA, Campbell JN. A new program
in pain medicine for medical students: integrating core curriculum knowledge
with emotional and reflective development. Pain Med. 2011 Feb;12(2):186-95.
5. Strain EC, Harrison JA, Bigelow GE. Induction
of opioid-dependent individuals onto buprenorphine and buprenorphine/naloxone
soluble-films. Clin Pharmacol Ther. 2011 Mar;89(3):443-9. 6. Wachtel LE, Jaffe R, Kellner CH. Electroconvulsive
therapy for psychotropic-refractory bipolar affective disorder and severe
self-injury and aggression in an 11-year-old autistic boy. Eur Child
Adolesc Psychiatry. 2011 Mar;20(3):147-52. 1. Arria AM, Caldeira KM, Kasperski SJ, Vincent
KB, Griffiths RR, O'Grady KE.Energy drink consumption and increased
risk for alcohol dependence. Alcohol Clin Exp Res. 2011 Feb;35(2):365-75. 2. Bienvenu OJ, Neufeld KJ. Post-traumatic stress
disorder in medical settings: focus on the critically ill. Curr Psychiatry
Rep. 2011 Feb;13(1):3-9. 3. Lyketsos CG, Weiller E, Katona C, Gorwood P.
Are old-old patients with major depression more likely to relapse than
young-old patients during continuation treatment with escitalopram?
BMC Geriatr. 2011 Jan 14;11(1):2. 4. Maag D, Maxwell MJ, Hardesty DA, Boucher KL,
Choudhari N, Hanno AG, Ma JF, Snowman AS, Pietropaoli JW, Xu R, Storm
PB, Saiardi A, Snyder SH, Resnick AC. Inositol polyphosphate multikinase
is a physiologic PI3-kinase that activates Akt/PKB. Proc Natl Acad Sci
U S A. 2011 Jan 25;108(4):1391-6. 5. Smith GS, Workman CI, Kramer E, Hermann CR,
Ginsberg R, Ma Y, Dhawan V, Chaly T, Eidelberg D. The relationship between
the acute cerebral metabolic response to citalopram and chronic citalopram
treatment outcome. Am J Geriatr Psychiatry. 2011 Jan;19(1):53-63. 6. Tristan C, Shahani N, Sedlak TW, Sawa A. The
diverse functions of GAPDH: views from different subcellular compartments.
Cell Signal. 2011 Feb;23(2):317-23. 7. Wilcox HC. Method used in an unsuccessful suicide
attempt predicts likelihood of future completed suicide. Evid Based
Ment Health. 2011 Feb;14(1):16. 1. Abazyan B, Nomura J, Kannan G, Ishizuka K,
Tamashiro KL, Nucifora F, Pogorelov V, Ladenheim B, Yang C, Krasnova
IN, Cadet JL, Pardo C, Mori S, Kamiya A, Vogel MW, Sawa A, Ross CA,
Pletnikov MV. Prenatal interaction of mutant DISC1 and immune activation
produces adult psychopathology. Biol Psychiatry. 2010 Dec 15;68(12):1172-81.
2. Appleby BS, Lyketsos CG. Rapidly progressive
dementias and the treatment of human prion diseases. Expert Opin Pharmacother.
2011 Jan;12(1):1-12. 3. Bienvenu OJ, Davydow DS, Kendler KS. Psychiatric
'diseases' versus behavioral disorders and degree of genetic influence.
Psychol Med. 2011 Jan;41(1):33-40. 4. Cascella NG, Kryszak D, Bhatti B, Gregory P,
Kelly DL, Mc Evoy JP, Fasano A, Eaton WW. Prevalence of celiac disease
and gluten sensitivity in the United States clinical antipsychotic trials
of intervention effectiveness study population. Schizophr Bull. 2011
Jan;37(1):94-100. 5. Coughlin JW, Edwards RR, Redgrave GW, Guarda
AS. Pain severity in eating disorders predicts longer inpatient hospitalization.
Int J Eat Disord. 2010 Dec;43(8):737-42. 6. Fagan PJ, Schuster AB, Boyd C, Marsteller JA,
Griswold M, Murphy SM, Dunbar L, Forrest CB. Chronic care improvement
in primary care: evaluation of an integrated pay-for-performance and
practice-based care coordination program among elderly patients with
diabetes. Health Serv Res. 2010 Dec;45(6 Pt 1):1763-82. 7. Frosch E, McCulloch J, Yoon Y, Dosreis S. Pediatric
emergency consultations: prior mental health service use in suicide
attempters. J Behav Health Serv Res. 2011 Jan;38(1):68-79. 8. Jones HE, Kaltenbach K, Heil SH, Stine SM,
Coyle MG, Arria AM, O'Grady KE, Selby P, Martin PR, Fischer G. Neonatal
abstinence syndrome after methadone or buprenorphine exposure. N Engl
J Med. 2010 Dec 9;363(24):2320-31. 9. Landa RJ, Holman KC, O'Neill AH, Stuart EA.
Intervention targeting development of socially synchronous engagement
in toddlers with autism spectrum disorder: a randomized controlled trial.
J Child Psychol Psychiatry. 2011 Jan;52(1):13-21. 10. Liang NC, Bello NT, Moran TH. Experience with
activity based anorexia enhances conditioned taste aversion learning
in rats. Physiol Behav. 2011 Jan 10;102(1):51-7. 11. López-Arvizu C, Sparrow EP, Strube
MJ, Slavin C, Deoleo C, James J, Hoover-Fong J, McIntosh I, Tierney
E. Increased symptoms of attention deficit hyperactivity disorder and
major depressive disorder symptoms in nail-patella syndrome: Potential
association with LMX1B loss-of-function. Am J Med Genet B Neuropsychiatr
Genet. 2011 Jan;156(1):59-66. 12. Mielke MM, Bandaru VV, McArthur JC, Chu M,
Haughey NJ. Disturbance in cerebral spinal fluid sphingolipid content
is associated with memory impairment in subjects infected with the human
immunodeficiency virus. J Neurovirol. 2010 Dec;16(6):445-56. 13. Ross CA, Tabrizi SJ. Huntington's disease:
from molecular pathogenesis to clinical treatment. Lancet Neurol. 2011
Jan;10(1):83-98. 14. Schretlen DJ, van der Hulst EJ, Pearlson GD,
Gordon B. A neuropsychological study of personality: trait openness
in relation to intelligence, fluency, and executive functioning. J Clin
Exp Neuropsychol. 2010 Dec;32(10):1068-73. 15. Turin E, Grados MA, Tierney E, Ferenc LM,
Zabel A, Comi AM. Behavioral and psychiatric features of Sturge-Weber
syndrome. J Nerv Ment Dis. 2010 Dec;198(12):905-13. 1. Avramopoulos D. Genetics of psychiatric disorders
methods: molecular approaches. Clin Lab Med. 2010 Dec;30(4):815-27.
2. Consoli A, Benmiloud M, Wachtel L, Dhossche
D, Cohen D, Bonnot O. Electroconvulsive therapy in adolescents with
the catatonia syndrome: efficacy and ethics. J ECT. 2010 Dec;26(4):259-65.
3. Coughlin JW, Edwards RR, Redgrave GW, Guarda
AS. Pain severity in eating disorders predicts longer inpatient hospitalization.
Int J Eat Disord. 2010 Dec;43(8):737-42. 4. Fagan PJ, Schuster AB, Boyd C, Marsteller JA,
Griswold M, Murphy SM, Dunbar L,Forrest CB. Chronic care improvement
in primary care: evaluation of an integrated pay-for-performance and
practice-based care coordination program among elderly patients with
diabetes. Health Serv Res. 2010 Dec;45(6 Pt 1):1763-82. 5. Johnson AW, Han S, Blouin AM, Saini J, Worley
PF, During MJ, Holland PC, Baraban JM, Reti IM. Localized disruption
of Narp in medial prefrontal cortex blocks reinforcer devaluation performance.
Learn Mem. 2010 Nov 22;17(12):620-6. 6. Johnston D, Smith M, Beard-Byrd K, Albert A,
Legault C, McCall WV, Singleton A, Brenes G, Hogan P, Reifler B. A new
home-based mental health program for older adults: description of the
first 100 cases. Am J Geriatr Psychiatry. 2010 Dec;18(12):1141-5. 7. Mielke MM, Lyketsos CG. Alterations of the
sphingolipid pathway in Alzheimer's disease: new biomarkers and treatment
targets? Neuromolecular Med. 2010 Dec;12(4):331-40. 8. Mielke MM, Zandi PP, Shao H, Waern M, Ostling
S, Guo X, Björkelund C, Lissner L, Skoog I, Gustafson DR. The 32-year
relationship between cholesterol and dementia from midlife to late life.
Neurology. 2010 Nov 23;75(21):1888-95. 9. Schlund MW, Cataldo MF. Amygdala involvement
in human avoidance, escape and approach behavior. Neuroimage. 2010 Nov
1;53(2):769-76. 10. Wachtel LE, Crawford TO, Dhossche DM, Reti
IM. Electroconvulsive therapy for pediatric malignant catatonia with
cerebellar dysgenesis. Pediatr Neurol. 2010 Dec;43(6):427-30. 11. Wilcox HC, Arria AM, Caldeira KM, Vincent
KB, Pinchevsky GM, O'Grady KE. Prevalence and predictors of persistent
suicide ideation, plans, and attempts during college. J Affect Disord.
2010 Dec;127(1-3):287-94. 12. Zandi PP, Judy JT. The promise and reality
of pharmacogenetics in psychiatry. Clin Lab Med. 2010 Dec;30(4):931-74.
1. Bello NT, Hajnal A. Dopamine and binge eating
behaviors. Pharmacol Biochem Behav. 2010 Nov;97(1):25-33. 2. Boyle L, Kaufmann WE. The behavioral phenotype
of FMR1 mutations. Am J Med Genet C Semin Med Genet. 2010 Nov 15;154C(4):469-76.
3. Jones HE, O'Grady KE, Johnson RE, Velez M,
Jansson LM. Infant neurobehavior following prenatal exposure to methadone
or buprenorphine: results from the neonatal intensive care unit network
neurobehavioral scale. Subst Use Misuse.2010 Nov;45(13):2244-57. 4. Knoepp LR, Shippey SH, Chen CC, Cundiff GW,
Derogatis LR, Handa VL. Sexual complaints, pelvic floor symptoms, and
sexual distress in women over forty. J Sex Med. 2010 Nov;7(11):3675-82.
5. Kuramoto SJ, Stuart EA, Runeson B, Lichtenstein
P, Långström N, Wilcox HC. Maternal or paternal suicide and
offspring's psychiatric and suicide-attempt hospitalization risk. Pediatrics.
2010 Nov;126(5):e1026-32. 6. O'Brien JW, Dowell LR, Mostofsky SH, Denckla
MB, Mahone EM. Neuropsychological profile of executive function in girls
with attention-deficit/hyperactivity disorder. Arch Clin Neuropsychol.
2010 Nov;25(7):656-70. 7. Reese JB, Somers TJ, Keefe FJ, Mosley-Williams
A, Lumley MA. Pain and functioning of rheumatoid arthritis patients
based on marital status: is a distressed marriage preferable to no marriage?
J Pain. 2010 Oct;11(10):958-64. 1. Burstein M, Ginsburg GS, Tein JY. Parental
anxiety and child symptomatology: an examination of additive and interactive
effects of parent psychopathology. J Abnorm Child Psychol. 2010 Oct;38(7):897-909.
2. Chisolm MS, Brigham EP, Lookatch SJ, Tuten
M, Strain EC, Jones HE. Cigarette smoking knowledge, attitudes, and
practices of patients and staff at a perinatal substance abuse treatment
center. J Subst Abuse Treat. 2010 Oct;39(3):298-305. 3. Duan W, Ross CA. Potential therapeutic targets
for neurodegenerative diseases: lessons learned from calorie restriction.
Curr Drug Targets. 2010 Oct;11(10):1281-92. 4. Eze-Nliam CM, Thombs BD, Lima BB, Smith CG,
Ziegelstein RC. The association of depression with adherence to antihypertensive
medications: a systematic review. J Hypertens. 2010 Sep;28(9):1785-95.
5. Hayashi-Takagi A, Sawa A. Disturbed synaptic
connectivity in schizophrenia: convergence of genetic risk factors during
neurodevelopment. Brain Res Bull. 2010 Sep 30;83(3-4):140-6. 6. Lee RS, Tamashiro KL, Yang X, Purcell RH, Harvey
A, Willour VL, Huo Y, Rongione M, Wand GS, Potash JB. Chronic corticosterone
exposure increases expression and decreases deoxyribonucleic acid methylation
of Fkbp5 in mice. Endocrinology. 2010 Sep; 151(9):4332-43. 7. Mintzer MZ, Lanier RK, Lofwall MR, Bigelow
GE, Strain EC. Effects of repeated tramadol and morphine administration
on psychomotor and cognitive performance in opioid-dependent volunteers.
Drug Alcohol Depend. 2010 Oct 1;111(3):265-8. 8. Wong DF, Kuwabara H, Horti AG, Raymont V, Brasic
J, Guevara M, Ye W, Dannals RF, Ravert HT, Nandi A, Rahmim A, Ming JE,
Grachev I, Roy C, Cascella N. Quantification of cerebral cannabinoid
receptors subtype 1 (CB1) in healthy subjects and schizophrenia by the
novel PET radioligand [11C]OMAR. Neuroimage. 2010 Oct 1;52(4):1505-13.
1. Bello NT, Kemm MH, Ofeldt EM, Moran TH. Dose
combinations of exendin-4 and salmon calcitonin produce additive and
synergistic reductions in food intake in nonhuman primates. Am J Physiol
Regul Integr Comp Physiol. 2010 Sep;299(3):R945-52. 2. Bolla KI, Lesage SR, Gamaldo CE, Neubauer DN,
Wang NY, Funderburk FR, Allen RP, David PM, Cadet JL. Polysomnogram
changes in marijuana users who report sleep disturbances during prior
abstinence. Sleep Med. 2010 Oct;11(9):882-9. 3. Campbell CM, Quartana PJ, Buenaver LF, Haythornthwaite
JA, Edwards RR. Changes in situation-specific pain catastrophizing precede
changes in pain report during capsaicin pain: a cross-lagged panel analysis
among healthy, pain-free participants. J Pain. 2010 Sep;11(9):876-84.
4. Eze-Nliam CM, Thombs BD, Lima BB, Smith CG,
Ziegelstein RC. The association of depression with adherence to antihypertensive
medications: a systematic review. J Hypertens. 2010 Sep;28(9):1785-95.
5. Fishman MJ, Winstanley EL, Curran E, Garrett
S, Subramaniam G. Treatment of opioid dependence in adolescents and
young adults with extended release naltrexone: preliminary case-series
and feasibility. Addiction. 2010 Sep;105(9):1669-76. 6. Johnson MW, Strain EC, Griffiths RR. Effects
of oral caffeine pretreatment on response to intravenous nicotine and
cocaine. Exp Clin Psychopharmacol. 2010 Aug;18(4):305-15. 7. Lee RS, Tamashiro KL, Yang X, Purcell RH, Harvey
A, Willour VL, Huo Y, Rongione M, Wand GS, Potash JB. Chronic corticosterone
exposure increases expression and decreases deoxyribonucleic acid methylation
of Fkbp5 in mice. Endocrinology. 2010 Sep;151(9):4332-43. 8. Locascio G, Mahone EM, Eason SH, Cutting LE.
Executive dysfunction among children with reading comprehension deficits.
J Learn Disabil. 2010 Sep-Oct;43(5):441-54. 9. Mielke MM, Haughey NJ, Ratnam Bandaru VV, Schech
S, Carrick R, Carlson MC, Mori S, Miller MI, Ceritoglu C, Brown T, Albert
M, Lyketsos CG. Plasma ceramides are altered in mild cognitive impairment
and predict cognitive decline and hippocampal volume loss. Alzheimers
Dement. 2010 Sep;6(5):378-85. 10. Ramsey CM, Leoutsakos JM, Mayer LS, Eaton
WW, Lee HB. History of manic and hypomanic episodes and risk of incident
cardiovascular disease: 11.5 year follow-up from the Baltimore Epidemiologic
Catchment Area Study. J Affect Disord. 2010 Sep;125(1-3):35-41. 11. Rosenblatt A, Gao J, Mackell J, Richardson
S. Efficacy and safety of donepezil in patients with Alzheimer's disease
in assisted living facilities. Am J Alzheimers Dis Other Demen. 2010
Sep;25(6):483-9. 1. Aretouli E, Brandt J. Episodic memory in dementia:
Characteristics of new learning that differentiate Alzheimer's, Huntington's,
and Parkinson's diseases. Arch Clin Neuropsychol. 2010 Aug;25(5):396-409.
2. Cascella NG, Fieldstone SC, Rao VA, Pearlson
GD, Sawa A, Schretlen DJ. Gray-matter abnormalities in deficit schizophrenia.
Schizophr Res. 2010 Jul;120(1-3):63-70. 3. Duke AN, Correia CJ, Walsh SL, Bigelow GE,
Strain EC. Acute effects of intramuscular and sublingual buprenorphine
and buprenorphine/naloxone in non-dependent opioid abusers. Psychopharmacology
(Berl). 2010 Aug;211(3):303-12. 4. Jiang M, Porat-Shliom Y, Pei Z, Cheng Y, Xiang
L, Sommers K, Li Q, GillardonF, Hengerer B, Berlinicke C, Smith WW,
Zack DJ, Poirier MA, Ross CA, Duan W. Baicalein reduces E46K alpha-synuclein
aggregation in vitro and protects cells against E46K alpha-synuclein
toxicity in cell models of familiar Parkinsonism. J Neurochem. 2010
Jul;114(2):419-29. 5. Lehmann SW. A longitudinal "teaching-to-teach"
curriculum for psychiatric residents. Acad Psychiatry. 2010 Jul-Aug;34(4):282-6.
6. Murinson BB, Klick B, Haythornthwaite JA, Shochet
R, Levine RB, Wright SM. Formative experiences of emerging physicians:
gauging the impact of events that occur during medical school. Acad
Med. 2010 Aug;85(8):1331-1337. 7. Young-Pearse TL, Suth S, Luth ES, Sawa A, Selkoe
DJ. Biochemical and functional interaction of disrupted-in-schizophrenia
1 and amyloid precursor protein regulates neuronal migration during
mammalian cortical development. J Neurosci. 2010 Aug 4;30(31):10431-40.
1. Mahon PB, Stütz
AM, Seifuddin F, Huo Y, Goes FS, Jancic D, Judy JT, Depaulo JR Jr, Gershon
ES, McMahon FJ, Zandi PP, Potash JB, Willour VL. Case-control association
study of TGOLN2 in attempted suicide. Am J Med Genet B Neuropsychiatr
Genet. 2010 Jul;153B(5):1016-23. 2. Subramaniam S, Mealer RG, Sixt KM, Barrow RK,
Usiello A, Snyder SH. Rhes, a physiologic regulator of sumoylation,
enhances cross-sumoylation between the basic sumoylation enzymes E1
and Ubc9. J Biol Chem. 2010 Jul 2;285(27):20428-32. 3. Tamashiro KL, Moran TH. Perinatal environment
and its influences on metabolic programming of offspring. Physiol Behav.
2010 Jul 14;100(5):560-6. 4. Tompkins DA, Lanier RK, Harrison JA, Strain
EC, Bigelow GE. Human abuse liability assessment of oxycodone combined
with ultra-low-dose naltrexone. Psychopharmacology (Berl). 2010 Jul;210(4):471-80. 5. Wachtel LE, Dhossche DM. Self-injury
in autism as an alternate sign of catatonia: implications for electroconvulsive
therapy. Med Hypotheses. 2010 Jul;75(1):111-4. 1. Burstein M, Ginsburg
GS. The effect of parental modeling of anxious behaviors and cognitions
in school-aged children: an experimental pilot study. Behav Res Ther.
2010 Jun;48(6):506-15. 2. D'Agati D, Bloch Y, Levkovitz Y, Reti I. rTMS
for adolescents: Safety and efficacy considerations. Psychiatry Res.
2010 May 30;177(3):280-285. 3. Leoutsakos JM, Zandi PP, Bandeen-Roche K, Lyketsos
CG. Searching for valid psychiatric phenotypes: discrete latent variable
models. Int J Methods Psychiatr Res. 2010 Jun;19(2):63-73. 4. Sieber FE, Gottshalk A, Zakriya KJ, Mears SC,
Lee H. General anesthesia occurs frequently in elderly patients during
propofol-based sedation and spinal anesthesia. J Clin Anesth. 2010 May;22(3):179-83. 5. Wachtel LE, Hermida A, Dhossche DM. Maintenance
electroconvulsive therapy in autistic catatonia: a case series review.
Prog Neuropsychopharmacol Biol Psychiatry. 2010 May 30;34(4):581-7.
1. Campbell CM, Witmer
K, Simango M, Carteret A, Loggia ML, Campbell JN, Haythornthwaite JA,
Edwards RR. Catastrophizing delays the analgesic effect of distraction.
Pain. 2010 May;149(2):202-7. 2. Cone EJ, Zichterman
A, Heltsley R, Black DL, Cawthon B, Robert T, Moser F, Caplan YH. Urine
testing for norcodeine, norhydrocodone, and noroxycodone facilitates
interpretation and reduces false negatives. Forensic Sci Int. 2010 May
20;198(1-3):58-61. 3. Dailey MJ, Tamashiro KL, Terrillion CE,
Moran TH. Nutrient specific feeding and endocrine effects of jejunal
infusions. Obesity (Silver Spring). 2010 May;18(5):904-10. 4. Huete JM, Kurtz PF. Therapist effects
on functional analysis outcomes with young children. Res Dev Disabil.
2010 May-Jun;31(3):804-10. 5. Kidorf M, King VL, Peirce J, Burke C,
Kolodner K, Brooner RK. Psychiatric distress, risk behavior, and treatment
enrollment among syringe exchange participants. Addict Behav. 2010 May;35(5):499-503. 6. Quartana PJ, Wickwire EM, Klick B, Grace
E, Smith MT. Naturalistic changes in insomnia symptoms and pain in temporomandibular
joint disorder: a cross-lagged panel analysis. Pain. 2010 May;149(2):325-31.
7. Schretlen DJ, Vannorsdall TD, Winicki
JM, Mushtaq Y, Hikida T, Sawa A, Yolken RH, Dickerson FB, Cascella NG.
Neuroanatomic and cognitive abnormalities related to herpes simplex
virus type 1 in schizophrenia. Schizophr Res. 2010 May;118(1-3):224-31.
Return to top of Publications - Psychiatry Archives
|
 |
|
||||||||||||||||||||||||||||||||||||||
|
|
|
|
|
JHM Appointments | Employment @ JHM | Finding a Doctor | Disclaimer | Maps & Directions | Contact JHM |
|
|
